REGISTER
SIGN IN
Biocard Strep A Test
MPIN: MP41157
Sign in to view price
Biocard Strep A is a rapid simple and reliable immuno chromatographic test for the qualitative detection of group A Streptococci from a throat swab sample.
Ask for Quote
Biocard Strep A is a rapid simple and reliable immuno chromatographic test for the qualitative detection of group A Streptococci from a throat swab sample.
Benefits
Positive control included.Long shelf life of 18 months.CE marked.
Specification
Biocard Strep A Test (Stick throat swab sample) 20 tests Cat. 3017420.
Shipping Policy
Orders made at Medpick are initiated and processed for shipment upon receipt of request from the customer. Please note that our Shipping Services (Fee, Transportation, Loss or Damage of any shipment, etc.) are in accordance with the Seller\'s terms of Shipment.
Refund Policy
Please refer to Medpick Return Policy.
Cancellation / Return / Exchange Policy
Please refer to Medpick Return Policy.
Related products
-
Laboratory Infrastructure
Neoscreen IRT
Cystic Fibrosis (CF) is an autosomal recessive disorder affecting the lungs, pancreas, intestine and liver. CF is the most common in Caucasians with an incidence rate 1:2500 newborns. CF is caused by mutation in the gene for the protein cystic fibrosis transmembrane conductance regulator (CTFR) [1,2]. Large-scale neonatal screening for CF is performed by indentification of increased levels of immunoreactive trypsinogen (IRT) in blood.
SKU: MP40991 -
Laboratory Infrastructure
TissueTek Xpress x Series
Say Goodnight to Overnight tissue processing The Tissue-Tek® Xpress® x120 Continuous Rapid Tissue Processor is a self-contained tissue processor employing microwave and vacuum infiltration techniques. The instrument performs automatic rapid processing (fixation, dehydration, clearing, and paraffin impregnation) of tissue specimens in preparation for histological study and examination.
SKU: MP40947 -
Laboratory Infrastructure
Neoscreen G6PD
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is the most common human enzyme deficiency; an estimated 400 million people worldwide are affected by this enzymopathy (6). With regards to the demographics of G6PD deficiency, most of the affected individuals reside in Africa, the Middle East, and Southeast Asia. The G6PD enzyme catalyzes an oxidation/reduction reaction.
SKU: MP40989 -
Laboratory Infrastructure
Neoscreen Biotinidase
Labsystems Diagnostics’ Neonatal Toxoplasma gondii IgM FEIA is a fluorometric enzyme immunoassay intended for the determination of IgM-class antibodies to Toxoplasma gondii in blood samples dried on filter paper. The test is intended as a primary method for screening newborns for congenital toxoplasmosis (CT).
SKU: MP40993
